5-Methyl-2-furanmethanethiol
| Common Name: |
5-Methyl-2-furanmethanethiol |
| IUPAC Name: |
(5-methylfuran-2-yl)methanethiol |
| Molecular Formula: |
C12H17NO2 |
| SMILES: |
CC1=CC=C(O1)CS |
| Inchi: |
1S/C6H8OS/c1-5-2-3-6(4-8)7-5/h2-3,8H,4H2,1H3 |
| Inchi Key: |
MGLMZOFGBDYNMH-UHFFFAOYSA-N |
| Cas No: |
59303-05-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
0 |
| Name |
Value |
| Molecular Weight (g/mol) |
207.27 |
| Mass (g/mol) |
128.03 |
| Molar Refractivity |
61.45 |
| Net Charge |
|
| HBD |
1 |
| HBA |
2 |
| Rt Bonds |
5 |
| Rings |
1 |
| TPSA |
38.33 |
| Hetero Atoms |
2 |
| Heavy Atoms |
15 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
177.00 to 179.00 |
| Vapor Pressure (mmHg@25.00 °C) |
1.259 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.42 |
| LogP |
2.018 |
| iLOGP |
2.69 |
| XLOGP3 |
3.64 |
| WLOGP |
2.35 |
| MLOGP |
2.51 |
| ESOL Log S |
-3.38 |
| ESOL Solubility (mg/ml) |
0.086 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-4.13 |
| Ali Solubility (mg/ml) |
0.02 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-3.76 |
| Silicos-IT Solubility (mg/ml) |
0.04 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-4.98 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.452 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.227 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Danger |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
